Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form


Wilson, Matthew Brian (2004) THE ROLE OF SRC FAMILY TYROSINE KINASES IN BCR-ABL SIGNAL TRANSDUCTION AND CHRONIC MYELOGENOUS LEUKEMIA. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Primary Text

Download (3MB) | Preview


The hallmark of chronic myelogenous leukemia (CML) is the Philadelphia chromosome, which arises from the reciprocal translocation of the c-abl proto-onogene on chromosome 9 and the bcr locus on chromosome 22. This translocation results in the expression of a 210 kDa fusion protein (Bcr-Abl) with constitutive tyrosine kinase activity that is responsible for CML pathogenesis. Bcr-Abl activates several signaling proteins important for the proliferation and survival of myeloid progenitors, including the Src family kinases Hck and Lyn, the Stat5 transcription factor and upstream components of the Ras/Erk pathway. Previous work from our laboratory found that kinase-defective Hck blocks Bcr-Abl-induced transformation of DAGM myeloid leukemia cells to cytokine independence, suggesting that activation of the Src kinase family may be essential to oncogenic signaling by Bcr-Abl. Chapter II explores the contribution of Src kinases to Bcr-Abl signaling in vivo, using selective Src family kinase inhibitors. Inhibition of Src family kinases in Ph+ CML cell lines resulted in growth arrest, induction of apoptosis and blocked Stat5 and Erk activaton downstream. These data implicate the Src kinase family in Stat5 and Erk activation downstream of Bcr-Abl, and identify myeloid-specific Src kinases as potential drug targets in CML. In Chapter III, I investigated the biochemical interactions between myeloid Src family members and Bcr-Abl. Hck, Lyn and Fyn each bind the kinase domain, C-terminal tail, and SH3/SH2 region of Bcr-Abl and strongly phosphorylated the Bcr-Abl SH3-SH2 protein in vitro. Seven phosphorylated tyrosine residues were identified and substitution of these residues with phenylalanine in the context of full-length Bcr-Abl blocked transformation of TF-1 myeloid cells to cytokine independence. The position of several of these tyrosines in the crystal structure of c-Abl and transformation defect of the Bcr-Abl mutant suggest that phosphorylation by Src kinases may impact Bcr-Abl autoregulation and downstream oncogenic signaling. Taken together, these data firmly establish an important role for Src family tyrosine kinases in Bcr-Abl-mediated oncogenic signaling and implicate Src kinases as a promising therapeutic target for chronic myelogenous leukemia.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
Wilson, Matthew Brianmawst95@pitt.eduMAWST95
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairSmithgall, Thomas Etsmithga@pitt.eduTSMITHGA
Committee MemberRajasekaran, Baskaranbask@pitt.eduBASK
Committee MemberYalowich, Jack Cyalowich@pitt.eduYALOWICH
Committee MemberSchmidt, Martin Cmcs2@pitt.eduMCS2
Committee MemberSteinman, Richard Asteinman@pitt.eduSTEINMAN
Date: 21 December 2004
Date Type: Completion
Defense Date: 13 December 2004
Approval Date: 21 December 2004
Submission Date: 15 December 2004
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Biochemistry and Molecular Genetics
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: A-419259; CML; Mass Spectrometry; Stat5
Other ID:, etd-12152004-152152
Date Deposited: 10 Nov 2011 20:11
Last Modified: 15 Nov 2016 13:54


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item